The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
Mark Schweitzer
Advertisement
is global director of global analytical R&D at Abbott Laboratories in Abbott park, IL, and a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Analytical Technical Group (ATG).
Articles by Mark Schweitzer
Advertisement
Latest Updated Articles
- Implications and Opportunities of Applying QbD Principles to Analytical Measurement
Published: February 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
